| Code | Description | Claims | Beneficiaries | Total Paid |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
822 |
698 |
$51K |
| U0005 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 |
736 |
615 |
$15K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
397 |
390 |
$12K |
| G2023 |
Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
632 |
590 |
$11K |
| 87502 |
Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets |
127 |
125 |
$5K |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
285 |
181 |
$4K |
| 80053 |
Comprehensive metabolic panel |
600 |
584 |
$4K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
588 |
575 |
$3K |
| 82306 |
Vitamin D; 25 hydroxy, includes fraction(s), if performed |
183 |
180 |
$3K |
| 84443 |
Thyroid stimulating hormone (TSH) |
271 |
266 |
$3K |
| 86038 |
|
294 |
294 |
$2K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
36 |
36 |
$2K |
| 80061 |
Lipid panel |
229 |
226 |
$2K |
| 86803 |
|
201 |
199 |
$2K |
| 0001A |
|
47 |
47 |
$2K |
| 86160 |
|
137 |
133 |
$2K |
| 99202 |
Office or other outpatient visit for the evaluation and management of a new patient, straightforward |
37 |
37 |
$1K |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
327 |
313 |
$1K |
| 0002A |
|
39 |
39 |
$1K |
| 86140 |
|
394 |
387 |
$1K |
| 87340 |
|
192 |
190 |
$1K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
26 |
24 |
$1K |
| 84439 |
|
193 |
189 |
$1K |
| 87400 |
|
127 |
126 |
$932.61 |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
12 |
12 |
$814.30 |
| 83036 |
Hemoglobin; glycosylated (A1C) |
140 |
137 |
$787.90 |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
29 |
29 |
$770.18 |
| 86431 |
|
182 |
180 |
$607.99 |
| 85652 |
|
356 |
353 |
$564.65 |
| 81015 |
|
451 |
444 |
$498.51 |
| 87077 |
|
70 |
67 |
$374.74 |
| 81003 |
|
219 |
213 |
$305.38 |
| 86704 |
|
46 |
46 |
$302.18 |
| 87186 |
|
59 |
57 |
$283.19 |
| 87389 |
Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies |
15 |
15 |
$224.47 |
| 83550 |
|
47 |
47 |
$211.79 |
| 82550 |
|
55 |
54 |
$197.85 |
| 83540 |
|
46 |
46 |
$177.40 |
| 84403 |
|
14 |
14 |
$175.01 |
| 86039 |
|
27 |
27 |
$170.22 |
| 87807 |
|
25 |
24 |
$162.75 |
| 87449 |
|
25 |
24 |
$148.80 |
| 84146 |
|
15 |
15 |
$147.40 |
| 36415 |
Collection of venous blood by venipuncture |
95 |
93 |
$126.49 |
| 84481 |
|
13 |
13 |
$115.09 |
| 82728 |
|
13 |
13 |
$92.62 |
| 80048 |
Basic metabolic panel (calcium, ionized) |
13 |
13 |
$70.00 |
| 81001 |
|
30 |
28 |
$60.78 |
| 87634 |
|
47 |
45 |
$58.13 |
| 85004 |
|
372 |
360 |
$37.75 |
| 87798 |
Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism |
21 |
21 |
$29.05 |
| 82248 |
|
13 |
12 |
$17.87 |
| 99072 |
|
16 |
12 |
$0.00 |
| 91300 |
|
37 |
36 |
$0.00 |
| 84479 |
|
13 |
13 |
$0.00 |
| 84480 |
|
13 |
13 |
$0.00 |